XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Feb. 26, 2023
Feb. 27, 2022
Cash flows from operating activities:    
Net loss $ (63,992) $ (61,116)
Adjustments to reconcile net loss to net cash used in operating activities:    
Impairment of indefinite-lived intangible assets and goodwill 300 32,057
Depreciation, amortization of intangibles, debt costs and right-of-use assets 10,392 14,488
Gain on sale of BreatheWay (2,108) 0
Stock-based compensation expense 2,796 1,928
Deferred taxes 57 (5,471)
Loss on disposal of property and equipment related to restructuring, net 0 5,185
Other, net 101 (540)
Changes in current assets and current liabilities:    
Accounts receivable, net 8,994 (7,525)
Inventories (13,451) (11,910)
Prepaid expenses and other current assets (1,169) (1,448)
Accounts payable 11,405 13,507
Accrued compensation (1,895) (2,027)
Other accrued liabilities 8,570 (70)
Deferred revenue 1,792 662
Net cash used in operating activities (17,169) (22,045)
Cash flows from investing activities:    
Purchases of property and equipment (12,319) (18,539)
Working capital adjustments 0 2,390
Sale of Investment in non-public company 0 45,100
Proceeds from sales of property and equipment 0 1,096
Net cash provided by investing activities 3,347 98,767
Cash flows from financing activities:    
Proceeds from sale of common stock, net of issuance costs 4,822 0
Proceeds from long-term debt 3,367 0
Payments on long-term debt (3,199) (86,376)
Proceeds from lines of credit 18,400 45,011
Payments on lines of credit (42,400) (34,111)
Taxes paid for employee stock plans (274) (518)
Payments for debt issuance costs (3,669) (169)
Proceeds from sale of preferred stock, net of issuance costs 38,082 0
Net cash provided by (used in) financing activities 15,129 (76,163)
Net increase in cash and cash equivalents 1,307 559
Cash and cash equivalents, beginning of period 1,643 1,295
Cash and cash equivalents, end of period 2,950 1,854
Supplemental disclosure of non-cash investing and financing activities:    
Purchases of property and equipment on trade vendor credit 3,918 1,764
Convertible Preferred Stock PIK dividend (428) 0
Yucatan    
Adjustments to reconcile net loss to net cash used in operating activities:    
Loss on disposition of business 21,039 0
Cash flows from investing activities:    
Proceeds from the sale of BreatheWay, net 12,531 0
Eat Smart    
Adjustments to reconcile net loss to net cash used in operating activities:    
Loss on disposition of business 0 235
Cash flows from investing activities:    
Proceeds from the sale of BreatheWay, net 0 73,500
BreatheWay    
Cash flows from investing activities:    
Proceeds from the sale of BreatheWay, net $ 3,135 $ 0